European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis

Abstract

Between the first and this validation studies, the value of the ELF score as independent marker of skin and lung involvement in SSc is confirmed in 457 patients. A longitudinal study is on-going to identify an SSc specific algorithm with predictive value for skin and lung progression.